---
title: Salbutamol
date: "12-11-2025"
updated: "12-11-2025"
sources: ["BNF"]
---

<Callout>
  Short-acting beta-2 agonist (SABA) used for relief of bronchospasm in asthma
  and COPD. Rapid onset of action; use as reliever therapy.
</Callout>

---

## Indication

- Relief of acute bronchospasm in asthma and COPD; prevention of exercise-induced bronchospasm.

---

## Dose

- Inhaler (MDI): 100 mcg per puff (varies by device). Typical reliever dose is 1–2 puffs (100–200 mcg) every 4–6 hours as required; higher doses may be used for exacerbations under guidance.
- Nebuliser: 2.5 mg to 5 mg via nebuliser for acute severe bronchospasm (hospital setting).

---

## Administration

- Use with a spacer in children and for patients with poor inhaler technique. Ensure correct inhaler technique and device-specific instructions.

---

## Contraindications

<Alert type="error">- Hypersensitivity to salbutamol or excipients.</Alert>

---

## Adverse Reactions

- Tremor, palpitations, tachycardia, headache, hypokalaemia with high systemic doses.

---

## Pregnancy and Lactation

- Considered safe in pregnancy and lactation when clinically indicated; inhaled therapy preferred for bronchodilation.
